Sanofi India Limited — Others, 31-07-2025: Appointment

Sanofi India has announced a board meeting outcome, approving the financial results. For the quarter, revenue was ₹406.3 Cr and profit ₹69.5 Cr. Half-year revenue stood at ₹942.2 Cr with profit of ₹189.0 Cr. Key leadership changes include Ms. Renee Amonkar's retirement as Whole-time Director and Goa Site Director effective August 11. Concurrently, Mr. Mahadev Gawade has been appointed as the new Whole-time Director and Goa Site Director for three years, pending shareholder approval. This ensures continued leadership. Additionally, the company signed a distribution agreement with Emcure Pharma for its Oral Anti-diabetic products.